Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joep C Defesche

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Circulation|December 11, 2002
Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening populationMarina A W Umans-Eckenhausen, Eric J G Sijbrands, John J P Kastelein, et al.
Archives of Internal Medicine|January 14, 2003
Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemiaMarina A W Umans-Eckenhausen, Joep C Defesche, Marjel J van Dam, et al.
Annals of Clinical Biochemistry|March 8, 2008
High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutationsKhemanganee E Liyanage, Amanda J Hooper, Joep C Defesche, et al.
European Heart Journal|November 9, 2006
Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemiaOlga W Souverein, Joep C Defesche, Aeilko H Zwinderman, et al.
Nature Reviews. Disease Primers|December 9, 2017
Familial hypercholesterolaemiaJoep C Defesche, Samuel S Gidding, Mariko Harada-Shiba, et al.
Seminars in Vascular Medicine|June 17, 2004
Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The NetherlandsDavid Wonderling, Marina A W Umans-Eckenhausen, Dalya Marks, et al.
Molecular Genetics and Metabolism|February 12, 2009
Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analysesØystein L Holla, Sigve Nakken, Morten Mattingsdal, et al.
Atherosclerosis|July 18, 2016
Sequencing for LIPA mutations in patients with a clinical diagnosis of familial hypercholesterolemiaBarbara Sjouke, Joep C Defesche, Janine S E de Randamie, et al.
Expert Review of Cardiovascular Therapy|April 12, 2008
Familial hypercholesterolemia: current treatment and advances in managementRoeland Huijgen, Maud N Vissers, Joep C Defesche, et al.
European Heart Journal|December 19, 2009
The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathwayDaniëlla M Oosterveer, Jorie Versmissen, Mojgan Yazdanpanah, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Circulation|December 11, 2002
Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening populationMarina A W Umans-Eckenhausen, Eric J G Sijbrands, John J P Kastelein, et al.
Archives of Internal Medicine|January 14, 2003
Long-term compliance with lipid-lowering medication after genetic screening for familial hypercholesterolemiaMarina A W Umans-Eckenhausen, Joep C Defesche, Marjel J van Dam, et al.
Annals of Clinical Biochemistry|March 8, 2008
High-resolution melting analysis for detection of familial ligand-defective apolipoprotein B-100 mutationsKhemanganee E Liyanage, Amanda J Hooper, Joep C Defesche, et al.
European Heart Journal|November 9, 2006
Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemiaOlga W Souverein, Joep C Defesche, Aeilko H Zwinderman, et al.
Nature Reviews. Disease Primers|December 9, 2017
Familial hypercholesterolaemiaJoep C Defesche, Samuel S Gidding, Mariko Harada-Shiba, et al.
Seminars in Vascular Medicine|June 17, 2004
Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The NetherlandsDavid Wonderling, Marina A W Umans-Eckenhausen, Dalya Marks, et al.
Molecular Genetics and Metabolism|February 12, 2009
Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analysesØystein L Holla, Sigve Nakken, Morten Mattingsdal, et al.
Atherosclerosis|July 18, 2016
Sequencing for LIPA mutations in patients with a clinical diagnosis of familial hypercholesterolemiaBarbara Sjouke, Joep C Defesche, Janine S E de Randamie, et al.
Expert Review of Cardiovascular Therapy|April 12, 2008
Familial hypercholesterolemia: current treatment and advances in managementRoeland Huijgen, Maud N Vissers, Joep C Defesche, et al.
European Heart Journal|December 19, 2009
The risk of tendon xanthomas in familial hypercholesterolaemia is influenced by variation in genes of the reverse cholesterol transport pathway and the low-density lipoprotein oxidation pathwayDaniëlla M Oosterveer, Jorie Versmissen, Mojgan Yazdanpanah, et al.
Pageof 10